UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial

American journal of infection control, 2013-12, Vol.41 (12), p.1167-1172

2013

Link zum Volltext

Verfügbarkeit prüfen

Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia—a single center experience in 34 patients

Thrombosis research, 2005, Vol.116 (2), p.109-114

2005

Link zum Volltext

Verfügbarkeit prüfen

Taking a wider view on fetal/neonatal alloimmune thrombocytopenia

Thrombosis research, 2017-03, Vol.151, p.S100-S102

2017

Link zum Volltext

Verfügbarkeit prüfen

High Incidence of Alloimmunization to Platelets and Platelet Transfusion Refractoriness during Induction Therapy in Patients Diagnosed with Acute Myeloid Leukemia

Blood, 2015-12, Vol.126 (23), p.3484-3484

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti-HLA Antibodies in Neonatal Alloimmune Thrombocytopenia - Is There Any Clinical Significance?

Blood, 2015-12, Vol.126 (23), p.4647-4647

2015

Link zum Volltext

Verfügbarkeit prüfen

NPM1 Quantitative Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia Allows More Precise Selection of Patients for Allogeneic Stem Cell Transplantation without Affecting Their Survival

Blood, 2019-11, Vol.134 (Supplement_1), p.2603-2603

2019

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of Patients with Standard- or Intermediate-Risk Acute Myeloid Leukemia Presenting with Residual Disease after One Induction Cycle Is Improved If Remission Is Achieved Following Re-Induction Given By Day 14 Compared to Second-Line Therapy Given 24-40 Days after Induction

Blood, 2016-12, Vol.128 (22), p.3999-3999

2016

Link zum Volltext

Verfügbarkeit prüfen

Stem cell transplantation post invasive fungal infection is a feasible task

American journal of hematology, 2004-01, Vol.75 (1), p.6-11

2004

Link zum Volltext

Verfügbarkeit prüfen

FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (F/NAIT) - THE PREVALENCE VERSUS AWARENESS OF A LIFE-THREATENING CLINICAL CONDITION

הרפואה, 2019-03, Vol.158 (3), p.155

2019

Link zum Volltext

Verfügbarkeit prüfen

Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation

Leukemia & lymphoma, 2019-08, Vol.60 (10), p.2449-2456

2019

Link zum Volltext

Verfügbarkeit prüfen

Autologous Stem Cell Transplantation in Favorable Acute Myeloid Leukemia Is Associated with a Better Long-Term Prognosis: a Single Center Experience

Blood, 2016-12, Vol.128 (22), p.5819-5819

2016

Link zum Volltext

Verfügbarkeit prüfen

Semaphorin 3A Expression on Donor and Recipient Regulatory Cells: A Novel Pre-Transplant Biomarker Predicting the Development of Acute Graft-Versus-Host Disease

Blood, 2014-12, Vol.124 (21), p.3935-3935

2014

Link zum Volltext

Verfügbarkeit prüfen

Stable Blood Group Chimerism in Recipients of ABO Incompatible Allogeneic Stem Cell Transplantation

Blood, 2014-12, Vol.124 (21), p.1553-1553

2014

Link zum Volltext

Verfügbarkeit prüfen

Astarabine, a Pro-Drug of Cytarabine, Is Safe for Patients with Advanced Acute Leukemia. A Phase I/IIa Single Center Study in Relapsed/Refractory or Medically Unfit Patients

Blood, 2015-12, Vol.126 (23), p.3810-3810

2015

Link zum Volltext

Verfügbarkeit prüfen

Post-Engraftment Persistent Leukocytosis May Be An Independent Poor Prognostic Factor in Allogeneic Stem Cell Transplant Patients

Blood, 2011-11, Vol.118 (21), p.4574-4574

2011

Link zum Volltext

Verfügbarkeit prüfen

Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation

Transfusion (Philadelphia, Pa.), 2013-05, Vol.53 (5), p.1019-1023

2013

Link zum Volltext

Verfügbarkeit prüfen

Female Donor Allografts Have a Higher CD3 Content Than Male Donor Allografts: Potential Impact On Transplantation Outcomes in Male Recipients

Blood, 2012-11, Vol.120 (21), p.587-587

2012

Link zum Volltext

Verfügbarkeit prüfen

Fatal Kaposi sarcoma after allogeneic stem cell transplant

Leukemia & lymphoma, 2011-12, Vol.52 (12), p.2402-2404

2011

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies – A Curative Approach When Performed as a Primary Therapeutic Modality: A Single Center Experience

Blood, 2009-11, Vol.114 (22), p.1144-1144

2009

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: Risk stratified approach with a long-term follow-up

American journal of hematology, 2012-09, Vol.87 (9), p.875-879

2012

Link zum Volltext

Verfügbarkeit prüfen

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved

Blood, 2009-11, Vol.114 (22), p.1552-1552

2009

Link zum Volltext

Verfügbarkeit prüfen

Successful Long- Term Outcome and Chimeric Status Following Allogeneic Stem Cell Transplantation for Non-Malignant Disorders Using Moderate T Cell Depletion with No Post Transplant Gvhd Prophylaxis

Blood, 2008-11, Vol.112 (11), p.3292-3292

2008

Link zum Volltext

Verfügbarkeit prüfen

Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy

Biology of blood and marrow transplantation, 2016-06, Vol.22 (6), p.975-981

2016

Link zum Volltext

Verfügbarkeit prüfen

Current indications for reduced-intensity allogeneic stem cell transplantation

Best practice & research. Clinical haematology, 2004-09, Vol.17 (3), p.377-386

2004

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic Stem Cell Transplantation (ASCT) in CML with Partial T-Cell Depletion, No Prophylaxis for Graft-Versus-Host Disease (GvHD) and Preemptive DLI for Patients with Post-Transplant Minimal Residual Disease (MRD): An Alternative Approach in CML Transplantation with Low Morbidity and Long Term Disease Free Survival

Blood, 2006-11, Vol.108 (11), p.318-318

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(16)
Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Hematology
(14)
Female
(11)
Adult
(10)
Male
(9)
Middle Aged
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Adolescent
(5)
Aged
(5)
Retrospective Studies
(5)
Transplantation, Homologous
(5)
Treatment Outcome
(4)
Dna, Neoplasm - Biosynthesis
(3)
Hematologic And Hematopoietic Diseases
(3)
Hematology, Oncology And Palliative Medicine
(3)
Oncology
(3)
Receptors, Tumor Necrosis Factor - Physiology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial

Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia—a single center experience in 34 patients

Taking a wider view on fetal/neonatal alloimmune thrombocytopenia

High Incidence of Alloimmunization to Platelets and Platelet Transfusion Refractoriness during Induction Therapy in Patients Diagnosed with Acute Myeloid Leukemia

Anti-HLA Antibodies in Neonatal Alloimmune Thrombocytopenia - Is There Any Clinical Significance?

NPM1 Quantitative Monitoring of Minimal Residual Disease in Acute Myeloid Leukemia Allows More Precise Selection of Patients for Allogeneic Stem Cell Transplantation without Affecting Their Survival

Prognosis of Patients with Standard- or Intermediate-Risk Acute Myeloid Leukemia Presenting with Residual Disease after One Induction Cycle Is Improved If Remission Is Achieved Following Re-Induction Given By Day 14 Compared to Second-Line Therapy Given 24-40 Days after Induction

Stem cell transplantation post invasive fungal infection is a feasible task

FETAL/NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (F/NAIT) - THE PREVALENCE VERSUS AWARENESS OF A LIFE-THREATENING CLINICAL CONDITION

Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation

Autologous Stem Cell Transplantation in Favorable Acute Myeloid Leukemia Is Associated with a Better Long-Term Prognosis: a Single Center Experience

Semaphorin 3A Expression on Donor and Recipient Regulatory Cells: A Novel Pre-Transplant Biomarker Predicting the Development of Acute Graft-Versus-Host Disease

Stable Blood Group Chimerism in Recipients of ABO Incompatible Allogeneic Stem Cell Transplantation

Astarabine, a Pro-Drug of Cytarabine, Is Safe for Patients with Advanced Acute Leukemia. A Phase I/IIa Single Center Study in Relapsed/Refractory or Medically Unfit Patients

Post-Engraftment Persistent Leukocytosis May Be An Independent Poor Prognostic Factor in Allogeneic Stem Cell Transplant Patients

Alloimmune platelet transfusion refractoriness circumvented by allogeneic stem cell transplantation

Female Donor Allografts Have a Higher CD3 Content Than Male Donor Allografts: Potential Impact On Transplantation Outcomes in Male Recipients

Fatal Kaposi sarcoma after allogeneic stem cell transplant

Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies – A Curative Approach When Performed as a Primary Therapeutic Modality: A Single Center Experience

Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: Risk stratified approach with a long-term follow-up

For Standard and High-Risk Patients with Hodgkin Lymphoma Six Cycles of Tailored BEACOPP, Based On Interim Scintigraphy, Are Effective and Female Fertility Is Preserved

Successful Long- Term Outcome and Chimeric Status Following Allogeneic Stem Cell Transplantation for Non-Malignant Disorders Using Moderate T Cell Depletion with No Post Transplant Gvhd Prophylaxis

Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to Therapy

Current indications for reduced-intensity allogeneic stem cell transplantation

Suchergebnisse filtern